Abstract Submission for #LUPUS2025 is now OPEN! 🦋 Contribute to cutting-edge discussions and advancements in #LupusResearch at the 16th International Congress on Systemic Lupus Erythematosus. 🌐 Abstract submission deadline: Tuesday, 5 November 2024: lupus2025.kenes.com/abstract-submi…

In this study, interferon-γ was found to play a large role in the pathogenesis of APS-1. Results were confirmed in studies in animals and led to a trial of ruxolitinib in five patients, who had dramatic responses. Read the full study results: nej.md/4bXoKkG

June AC&R Editor's Pick ▶️ Development of the American College of Rheumatology’s Patient-reported Outcome Quality Measures for Systemic Lupus Erythematosus loom.ly/xaatnxs

Decorre hoje e amanhã, no Porto, a reunião Mayo Clinic Update, organizada conjuntamente pelo Serviço de Nefrologia do IPO do Porto e pelo Serviço de Nefrologia da Mayo Clinic, Rochester, E.U.A. Saiba mais aqui: lab52.pt/oportomayoclin…

Enjoyed a fantastic discussion on #lupusnephritis in beautiful Porto. Grateful for the opportunity!

Aproveitei uma discussão fantástica sobre #lupusnefrite na bela cidade do Porto. Grato pela oportunidade!

🆕 Higher #glucocorticoid doses boost renal outcomes in #LupusNephritis BUT worsen serious infections and mortality💀 📖ACR_Journals 😶‍🌫️Still foggy? We partnered with Rheum OnePagers Mithu Maheswaranathan, MD to shed light on the data 💡 #MedTwitter #RheumTwitter healio.com/news/rheumatol…

🦋 Visual Abstract with Healio Rheumatology 🟢 Glucocorticoid Dosing in #Lupus Nephritis: Impact of GC Dose on Renal Response, Infections and Mortality • Systematic Review & Meta-Analysis 📖 by Gabriel Figueroa-Parra, MD, MSc Alí Duarte, MD et al, A&R 🔗: tinyurl.com/HealioLN #Rheum #LupusNephritis

Matthew Baker M.D., M.S. Trends in opioid use for autoimmune rheumatic diseases Linked Comment by Erika P Navarro-Mendoza & Alí Duarte-García (Alí Duarte, MD) thelancet.com/journals/lanrh…

Congratulations to Dr. Connie Weyand for receiving the Lifetime Achievement Award from the California Rheumatology Alliance. On behalf of my colleagues, I express admiration and gratitude to Dr. Weyand for advancing the science of autoimmunity, leading our research programs, and

Here are the most FASCINATING facts I could find about Mexico: 1. Mexico is so huge it’s hard to comprehend. You can fit 30 European countries in Mexico and still have room to spare

🚨 We evaluated the performance of the new #APS criteria in 🇲🇽 🔸100% Sp in both primary and secondary APS 🔸 ‘Pure hematological’ APS doesn’t meet criteria 🔸 The criteria score correlates with GAPSS and DIAPS Erik Cimé-Aké Amaya Llorente Chávez, MD ACR_Journals acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

🆕 OMERACT SLE Domain Survey An enormous 🌎 effort for harmonization led by Wils Nielsen, PhD Candidate Sindhu Johnson MD PhD Aaron Drucker Zahi Touma, MD, PhD & OMERACT Ioannis Parodis Marta Mosca Laurent ARNAUD Alí Duarte, MD Manuel Ugarte-Gil Guillermo Pons Estel Eric Morand 🇺🇦 & cols #lupus sciencedirect.com/science/articl…

✅ MUST-READ paper ⬇️ about #glucocorticoids in #lupus #nephritis by the group of Alí Duarte, MD (actually a systematic review and meta-analysis of the control arms RCTs). With a great focus on the role of mPred infusions and optimal GC doses 👌 doi.org/10.1002/art.42…

Map of countries that speak Mexican 🇲🇽

Research shows that higher exposure to steroids during the initial treatment of #LupusNephritis was associated with better renal outcomes, but at the cost of increased infections and mortality. Read more in The Rheumatologist: ow.ly/BpJQ50TgHKI Gabriel Figueroa-Parra, MD, MSc Alí Duarte, MD

Why I love working at Mayo Clinic: 10 AM – Incidental PE on CT, asymptomatic. 11 AM – Labs done. 12 PM – Patient gets lunch. 1 PM – Thrombophilia clinic, Lovenox shot. 2 PM – Rheum clinic with me. 3 PM – DOAC ready at Mayo Pharmacy. Seamless, coordinated care at its best!

Very informative letter to the editor regarding the new SLE EULAR guidelines and using race/ethnicity for treatment decision making. ⤵️

Had a wonderful time at the #HONP+circle conference discussing #LupusNephritis and the new criteria for #APS. Until next time, Munich! 🇩🇪 honpluscircle.de

Contribute to unraveling the mysteries of #SLE heterogeneity and help advance #lupus care! 💜 If your work explores the variability in manifestations, responses to treatment, or genetic and environmental influences, we want your findings! 📢 Submit today: bit.ly/3Mazxx9